General Information
Revision date
2020-02-14
Product name
Naproxen Sodium Tablets, USP 275 mg & 550mg
Chemical name
(S)-6-methoxy-α-methyl-2-naphthaleneacetic acid, sodium salt
CAS No.
26159-34-2
1.2.1 Relevant identified uses
Anti-inflammatory, Analgesic
Manufacturer Name
ScieGen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
ScieGen Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
OSHA Not considered hazardous when handled under normal conditions. EMERGENCY OVERVIEW Caution Product poses little or no hazard if spilled and no unusual hazard if involved in a fire. Human effects and Symptoms of Overexposure Acute Effects of Exposure Exceeding the recommended dosage may cause nausea, vomiting, ringing in the ears or a loss of hearing occurs. Drowsiness, confusion, irregular heartbeat, headache, high blood pressure.
Potential chronic health
of Exposure Chronic over exposure to this product may cause effects as noted under acute over exposure. Routes of Entry Oral Carcinogenicity NTP: None IARC: None OSHA: None Medical Conditions Blood disorders, digestive disorders, kidney disorders, high blood pressure, do not take this product without first consulting a health professional, if you have any of the following conditions; pregnant or nursing a baby, stomach problems that last or come back frequently, gastrointestinal ulcers, bleeding problems, taking prescription medications, taking any other drug containing an NSAID (Prescription r nonprescription), taking a blood thinning (anticoagulant) or steroid drug.
